wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39177156-168A5413-6D56-4847-AA54-60881E31DF62
Q39177156-168A5413-6D56-4847-AA54-60881E31DF62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39177156-168A5413-6D56-4847-AA54-60881E31DF62
Baricitinib: First Global Approval.
P2860
Q39177156-168A5413-6D56-4847-AA54-60881E31DF62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39177156-168A5413-6D56-4847-AA54-60881E31DF62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c2e993d947073e87d9bd8b60ced96edd0d20f77
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.